Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

AFRY appointed as Owner’s Engineer for renewable power plant in Australia’s flagship green ammonia project

Allied Green Ammonia (AGA) has awarded AFRY the Owner’s Engineering assignment for its flagship green ammonia project in the Northern Territory, Australia. AFRY’s role covers the design of a reliable and self-sustaining renewable power and distribution system to supply electricity to AGA’s green ammonia production facility.Ammonia is an essential component in the chemical industry and in agricultural fertilisers, however, its conventional production generates significant carbon emissions. By using a 100% renewable energy in the production process, AGA’s green ammonia project, is envisioned

Acquisitions of own shares in Evolution AB (publ)

Evolution AB (publ) (“Evolution”) has, during the period 23 September - 27 September acquired a total of 199,684 own shares within the framework of the repurchase programme introduced by the board of directors to improve the capital structure of Evolution by reducing the capital, and thereby creating added shareholder value.The repurchase programme, which Evolution announced on 18 July 2024, is being implemented in accordance with the EU Market Abuse Regulation No 596/2014 (“MAR”) and Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”). During the period 23 September

Save the date for Cereno Scientific’s Capital Markets Day on October 17, 2024

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that the Company will hold a Capital Markets Day on October 17, 2024.The Capital Markets Day will provide an opportunity for investors, analysts, and media to get insights on Cereno’s clinical and preclinical development portfolio and operations as well as its future growth strategy. The program will include presentations by the Cereno executive management team as well as key external speakers. Cereno’s Capital Markets Day will

Jaakko Liljeroos will commence as the Chief Legal Officer of Pihlajalinna on 1 December 2024

Pihlajalinna Plc       Stock Exchange Release       30 September 2024 at 9:30 a.m. Jaakko Liljeroos will commence as the Chief Legal Officer of Pihlajalinna on 1 December 2024 Jaakko Liljeroos will commence as the Chief Legal Officer and as a member of the Management Team of Pihlajalinna Plc on 1 December 2024. As previously communicated in a Stock Exchange Release on 5 September 2024, Liljeroos is joining Pihlajalinna from Valmet Automotive, where he has been working as Group General Counsel since 2020. “I am happy to welcome Jaakko to Pihlajalinna and to be part of our management

GomSpace provides an end of quarter update on the Maritime Domain Awareness program in Indonesia

The government-to-government process on financing of the Maritime Domain Awareness program in Indonesia is ongoing.CEO, Carsten Drachmann comments:” It has been a long journey that started more than 3 years ago, and I know it seems like an even longer wait here at the end, but things will take the time they take, when it comes to government business. Our Danish Embassy in Jakarta is doing a fantastic job in supporting us and helping the deal to closure.” The Company summarizes the key milestones achieved towards closing the final contract for Marine Domain Awareness program with

Change in number of shares and votes in Immunovia AB (publ)

LUND (SWEDEN) – During September 2024, the registered number of shares and votes in Immunovia AB (publ) (“Immunovia”) has increased due to the rights issue of units resolved by the board of directors on 20 May 2024 and approved by the annual general meeting on 19 June 2024, as well as the directed issue of units to underwriters in the rights issue resolved by the board of directors on 12 September 2024, based on the authorization granted by the annual general meeting on 19 June 2024. As of 30 September 2024, the registered number of shares and votes in Immunovia amounts to 169,711,476.

Status update and guidance from Talkpool's board of directors

Talkpool AG (Nasdaq First North: TALK), a prominent player on the telecommunication network services market, today announced its readiness to enter a new growth phase following a highly successful two-year stabilization period.The company has dramatically improved its financial position, setting the stage for strategic expansion and increased market presence in the evolving telecom landscape. Financial Highlights: · Net debt reduced by 73%, from -€6.20 million in mid-2022 to -€1.65 million by mid-2024 · Equity improved by over €4.0 million, from -€3,576,884 in mid-2022 to €89,871

Capital increase in connection with exercise of issued warrants and partial payment of Pragmasoft acquisition

Company Announcement no. 14/202430 September 2024   The Board of Directors of Wirtek A/S issued 350,000 warrants in June 2020 following an authorisation given by the general meeting. Each warrant entitles the holder to subscribe for one Wirtek A/S share with a nominal value of DKK 0.15. The exercise price for the warrants was calculated at the time of issue to 5.35 DKK. The vesting period was set to three years, and the warrants could be exercised by the holders in the first exercise period from 1 May to 15 May 2023. Instructions and payments have been received to exercise a total

Cereno Scientific signs agreement with Fluidda, to evaluate the impact of its HDAC inhibitor CS1 on reverse remodeling of pulmonary vessels in patients with PAH

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced that the Company has signed an agreement with medical technology company Fluidda on Respiratory Imaging solutions, with the aim to visualize signs of reverse remodeling of lead drug candidate CS1 in Pulmonary Arterial Hypertension (PAH) in a clinical setting.“We have a vision to develop new therapies which address the root cause of cardiovascular disease as we believe this will provide high value to patients with respect to

BlueNord: Updated Tyra Production Guidance for Q4 2024

Oslo, 30 September 2024: Reference is made to stock exchange notice published by BlueNord ASA (“BlueNord” or the “Company”) on 30 August 2024 where the Tyra production guidance for Q3 and Q4 2024 was placed under review. The onshore repair of the second transformer is progressing well, and the transformer is expected offshore on the Tyra facilities in Q4 followed by installation and integration according to the plan. Thus, in line with operator’s earlier communicated REMIT (Details (gashub.at)), BlueNord expects production and ramp-up to continue into fourth quarter with maximum

Aker Solutions ASA: Aker Solutions secures Troll Phase 3 stage II topside modification contract

September 30, 2024 – Aker Solutions has been awarded a sizeable[1] EPCIC contract by Equinor to prepare the topside of Troll A for accelerating production from the Troll West gas reservoir.The Troll field is situated in the North Sea, 80 km northwest of Bergen, and is Norway’s largest gas producer, supplying 10 percent of Europe’s total gas needs. Troll Phase 3 involves producing the gas cap overlying the oil column in Troll West, while also continuing the production of oil. The produced gas goes to Troll A and onwards in existing infrastructure. The scope includes engineering,

Announcement of change in the total number of votes in AB SKF

Gothenburg, 30 September 2024: Due to a conversion of shares from Series A to Series B in accordance with AB SKF’s Articles of Association, the Company confirms the following.  As per 30 September 2024, there are a total of 455,351,068 shares in AB SKF, out of which 29,235,933 shares are of Series A and 426,115,135 shares are of Series B. The number of votes in the Company amounts to 71,847,446.5.  AB SKF does not hold any own shares.  Aktiebolaget SKF       (publ)  Information in this press release contains information that AB SKF is obliged to make public pursuant to the

New number of shares and votes in Sobi

As per 30 September 2024, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 356,000,049 shares. All shares are common shares. The total number of votes is 356,000,049. The increase in the number of shares and votes results from issues of 1,641,103 class C shares. The class C shares have been issued for the purpose of ensuring fulfilment of commitments under the long-term incentive programmes and have by virtue of the conversion clause in the articles of association been converted to common shares. As per 30 September 2024 the company holds 12,564,213 common

Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares

(Stockholm, Sweden, September 30, 2024) - Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced that as of September 30, 2024, the total number of issued shares of common stock is 83,487,293 of which 78,750,609 shares are outstanding.Autoliv retired 1,329,322 shares of common stock that had been repurchased during the quarter which resulted in a decrease in the issued shares. The Company now has a total of 83,487,293 issued shares of common stock of which 78,750,609 shares are outstanding. Each share of outstanding common stock is

SSAB and Smith Stål in cooperation on fossil-free steel

SSAB and Smith Stål from Norway have signed a letter of intent involving future deliveries of fossil-free steel. Together they are building a strong value chain for their Norwegian customers.Smith Stål is a leading stockist and nationwide distributor in Norway of value-added steels and metals including its own Steel Service Center. The company provides a complete stock of plates, beams, hollow sections, pipes and bars. “It is a great pleasure for our company that we in the future can deliver SSAB’s fossil-free steel to our customers in Norway. Being top 3 among Norwegian steel

Unaudited Net Asset Value Update (August 2024)

Monday, 30 September 2024 KR1 plc (“KR1” or the “Company”) Unaudited Net Asset Value Update KR1 plc (KR1:ASE), a leading digital asset investment company, is pleased to announce its unaudited net asset value ("NAV") as at 31 August 2024.   Net Asset Value £101,368,357NAV per share 57.27pGBP/USD rate 1.3131   Income from digital assets (*) £590,080 (*)     Positions (Top 10) by fair value:   Asset GBP equivalent % of portfolio  Celestia ("TIA"

Genova updates strategy and targets for strengthened profitable growth and decides on amended dividend policy with regular dividend payments

The Board of Directors of Genova has updated the company’s strategy and targets, and has adopted an amended dividend policy. In parallel, the company’s operational targets will cease to apply. Removing the operational targets will make Genova more flexible, enabling the company to focus on the property segments that offer the best potential for profitable growth. Under the amended dividend policy, at least one third of income from property management will be distributed to shareholders on a quarterly basis.  “Genova’s far-reaching expertise in the fields of property and finance, combined

Alejandro Corominas Menéndez appointed President and CEO of Loomis Europe and Latin America

Alejandro Corominas Menéndez has been appointed President and CEO of Loomis Europe and Latin America as of January 1, 2025. Currently, Alejandro holds the position as Country CEO of Loomis Spain and Regional Vice President for Loomis Europe and Latin America. Alejandro will report to the President and CEO of the Loomis Group and be a member of the Group Management team. Alejandro Corominas Menéndez, born in 1971, is a Spanish citizen who holds a B.Sc. in Economics and Business Administration and has completed the General Management Program at IESE Business School. With extensive

Increased number of shares and voting rights in Catena Media plc

Catena Media plc announces that the number of shares and voting rights in the company has increased by 1,020 due to the exercise of Catena Media warrants (CTM TO1) during the 18th and final warrant exercise period that followed publication of the interim report for the second quarter of 2024. As announced on 28 August 2024, 1,020 warrants were used to subscribe for the same number of new ordinary shares in Catena Media during the 18th warrant exercise period. The new shares were then registered with the Maltese authorities. As of 30 September 2024, the last trading day of the month,

Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting

Press Release – Oslo, Norway, September 30, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated that international multicenter Phase III clinical study data for its non-surgical treatment candidate Cevira[®] (APL-1702) for cervical High-Grade Squamous Intraepithelial Lesion (HSIL) has been published by the 27[th] Chinese Society of Clinical Oncology (CSCO) Annual Meeting as a poster, focusing on the analysis of different age subgroups regarding the six-month pathological regression rate and HPV clearance

Greenfood and Dagab strengthen collaboration in fresh-cut

Demand for convenient, everyday solutions continues to grow. To help consumers incorporate more greens into their diets, Greenfood and Dagab are expanding their partnership. As of January 16, 2025, Greenfood will become the primary supplier, delivering larger volumes of fresh-cut products to Dagab. This includes processed fruits and vegetables such as baby leaves in various mixes.Greenfood is one of Northern Europe’s leading players in sustainable and healthy foods. The company has experienced significant growth in recent years and continues to see rising demand as more people adopt plant-

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed Plc Stock Exchange Release 30 September 2024 at 8.40, Helsinki Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings Optomed Plc (“Optomed” or the “Company”) has received a notification in accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act (as amended, the “SMA”) from Danske Bank A/S (“Notifier”). According to the notification, the total holdings in Optomed shares and votes held the by DanskeBank A/S is 5.08 per cent of all of the registered shares in Optomed on 26 September 2024.   The total number

There are no items matching the current filter
There are no more items matching the current filter
Back to top